{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:58:50Z","timestamp":1781528330573,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073582"],"award-info":[{"award-number":["82073582"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515140169"],"award-info":[{"award-number":["2023A1515140169"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.tranon.2026.102705","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T16:46:52Z","timestamp":1771519612000},"page":"102705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["REST-driven upregulation of SFXN3 promotes AML progression via Wnt\/\u03b2-catenin activation and confers decitabine resistance"],"prefix":"10.1016","volume":"66","author":[{"given":"Xiaoling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.tranon.2026.102705_bib0001","article-title":"Synergistic targeting of DNA-PK and KIT signaling pathways in KIT mutant acute myeloid leukemia","volume":"22","author":"Murray","year":"2023","journal-title":"Mol. Cell. Prot. MCP"},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40364-023-00501-9","article-title":"Biomarkers as targets for CAR-T\/NK cell therapy in AML","volume":"11","author":"Shao","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.tranon.2026.102705_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215659","article-title":"Adenosine monophosphate activated protein kinase (AMPK) enhances chemotherapy response in acute myeloid leukemia (AML)","volume":"535","author":"Ghiraldeli","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.102705_bib0004","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-025-02685-5","article-title":"The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemia","author":"Rettinger","year":"2025","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.tranon.2026.102705_bib0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11912-024-01503-y","article-title":"Novel therapeutic targets in acute myeloid leukemia (AML)","volume":"26","author":"Wysota","year":"2024","journal-title":"Curr. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0006","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0007","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026849","article-title":"High throughput sequencing and assessing disease risk","volume":"9","author":"Rego","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0008","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10142-025-01529-w","article-title":"High-throughput sequencing: a breakthrough in molecular diagnosis for precision medicine","volume":"25","author":"Dongare","year":"2025","journal-title":"Funct. Integr. Genomics"},{"key":"10.1016\/j.tranon.2026.102705_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2018.01.006","article-title":"Gene mutation patterns of Chinese acute myeloid leukemia patients by targeted next-generation sequencing and bioinformatic analysis","volume":"479","author":"Han","year":"2018","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0010","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/s41467-021-22095-2","article-title":"HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia","volume":"12","author":"Zhu","year":"2021","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.tranon.2026.102705_bib0011","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5644\/ama2006-124.453","article-title":"The role of FLT3-ITD mutation, PI3K\/AKT pathway, and leukemia stem cells in D3A7 induction therapy - the outcomes of adult Indonesian patients with acute myeloid leukemia","volume":"53","author":"Arwanih","year":"2024","journal-title":"Acta Med. Acad."},{"issue":"3","key":"10.1016\/j.tranon.2026.102705_bib0012","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s12013-024-01326-5","article-title":"SFXN3 is a prognostic marker and promotes the growth of acute myeloid leukemia","volume":"82","author":"Jin","year":"2024","journal-title":"Cell Biochem. Biophys."},{"issue":"6416","key":"10.1016\/j.tranon.2026.102705_bib0013","first-page":"362","article-title":"SFXN1 is a mitochondrial serine transporter required for one-carbon metabolism","author":"Kory","year":"2018","journal-title":"Science (New York, N.Y.)"},{"issue":"13","key":"10.1016\/j.tranon.2026.102705_bib0014","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1111\/febs.16377","article-title":"The mitochondrial protein sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo","volume":"289","author":"Ledahawsky","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.tranon.2026.102705_bib0015","article-title":"Non-coding RNA-mediated high expression of SFXN3 as a prognostic biomarker associated with paclitaxel resistance and immunosuppressive microenvironment in head and neck cancer","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102705_bib0016","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031098","article-title":"The role played by wnt\/\u03b2-catenin signaling pathway in acute lymphoblastic leukemia","volume":"21","author":"Chiarini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.tranon.2026.102705_bib0017","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.tranon.2026.102705_bib0018","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamaoncol.2024.2662","article-title":"Contemporary Management of Acute Myeloid Leukemia: a review","volume":"10","author":"Venugopal","year":"2024","journal-title":"JAMA Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102705_bib0019","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/ajh.27600","article-title":"Biology and management of acute myeloid leukemia with mutated NPM1","volume":"100","author":"Chen","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.tranon.2026.102705_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117788","article-title":"Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: novel molecular approaches and therapeutic challenges","volume":"182","author":"Rataj","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0021","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood.2021013983","article-title":"TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia","volume":"140","author":"Tashakori","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.tranon.2026.102705_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253386","article-title":"Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia","volume":"16","author":"K\u00f6vy","year":"2021","journal-title":"PloS one"},{"issue":"5","key":"10.1016\/j.tranon.2026.102705_bib0023","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41375-024-02246-2","article-title":"Management of isocitrate dehydrogenase 1\/2 mutated acute myeloid leukemia","volume":"38","author":"Fruchtman","year":"2024","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.tranon.2026.102705_bib0024","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood.2020005498","article-title":"Geriatric assessment and survival among older adults receiving postremission therapy for acute myeloid leukemia","volume":"136","author":"Saad","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13578-025-01386-x","article-title":"The HNRNPC\/CELF2 signaling pathway drives glycolytic reprogramming and mitochondrial dysfunction in drug-resistant acute myeloid leukemia","volume":"15","author":"Ma","year":"2025","journal-title":"Cell Biosci."},{"key":"10.1016\/j.tranon.2026.102705_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.111004","article-title":"Mitocurcumin utilizes oxidative stress to upregulate JNK\/p38 signaling and overcomes cytarabine resistance in acute myeloid leukemia","volume":"114","author":"Gaur","year":"2024","journal-title":"Cell. Signal."},{"issue":"8","key":"10.1016\/j.tranon.2026.102705_bib0027","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1038\/s41375-025-02645-z","article-title":"Targeting lipid metabolism in acute myeloid leukemia: biological insights and therapeutic opportunities","volume":"39","author":"Dembitz","year":"2025","journal-title":"Leukemia"},{"key":"10.1016\/j.tranon.2026.102705_bib0028","doi-asserted-by":"crossref","first-page":"0","DOI":"10.3324\/haematol.2024.287265","article-title":"Metabolic reprogramming by PRDM16 drives cytarabine resistance in acute myeloid leukemia","author":"Ikeda","year":"2025","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0029","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40364-021-00293-w","article-title":"Functions of RNA N(6)-methyladenosine modification in acute myeloid leukemia","volume":"9","author":"Zheng","year":"2021","journal-title":"Biomark. Res."},{"key":"10.1016\/j.tranon.2026.102705_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.789914","article-title":"m6A Regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in acute myeloid leukemia","volume":"12","author":"Du","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0031","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s40246-025-00779-w","article-title":"Update of the sideroflexin (SLC56) gene family","volume":"19","author":"Katsafadou","year":"2025","journal-title":"Hum. Genomics"},{"issue":"9","key":"10.1016\/j.tranon.2026.102705_bib0032","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41419-022-05272-z","article-title":"Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.tranon.2026.102705_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-55907-z","article-title":"Sideroflexin 4 affects Fe-S cluster biogenesis, iron metabolism, mitochondrial respiration and heme biosynthetic enzymes","volume":"9","author":"Paul","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.tranon.2026.102705_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118763","article-title":"Hypomorphic CAMKK2 in EA.hy926 endothelial cells causes abnormal transferrin trafficking, iron homeostasis and glucose metabolism","volume":"1867","author":"Sabbir","year":"2020","journal-title":"Biochim. et Biophys. Acta Mol. Cell Res."},{"issue":"12","key":"10.1016\/j.tranon.2026.102705_bib0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1007\/s00335-007-9074-9","article-title":"An intronic sequence mutated in flexed-tail mice regulates splicing of Smad5","volume":"18","author":"Hegde","year":"2007","journal-title":"Mammal. Genom. Offic. J. Int. Mammal. Genom. Soc."},{"issue":"3","key":"10.1016\/j.tranon.2026.102705_bib0036","first-page":"462","article-title":"Sfxn5 Regulation of actin polymerization for neutrophil spreading depends on a citrate-cholesterol-PI(4,5)P2 pathway","volume":"211","author":"Zhang","year":"2023","journal-title":"J. Immun. (Baltimore, Md: 1950)"},{"issue":"12","key":"10.1016\/j.tranon.2026.102705_bib0037","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/15257770.2023.2218430","article-title":"Downregulation of fibrosis related hsa-miR-29c-3p in human CAKUT","volume":"42","author":"Macak","year":"2023","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"8068","key":"10.1016\/j.tranon.2026.102705_bib0038","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41586-025-08916-0","article-title":"Low overlap of transcription factor DNA binding and regulatory targets","volume":"642","author":"Mahendrawada","year":"2025","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tranon.2026.102705_bib0039","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41375-024-02470-w","article-title":"Acute myeloid leukemia associated RUNX1 variants induce aberrant expression of transcription factor TCF4","volume":"39","author":"Gerritsen","year":"2025","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.tranon.2026.102705_bib0040","first-page":"23","article-title":"RUNX1\/CEBPA mutation in acute myeloid leukemia promotes hypermethylation and indicates for demethylation therapy","author":"Romanova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.tranon.2026.102705_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23126729","article-title":"Combined approach to leukemic differentiation using transcription factor PU.1-enhancing agents","volume":"23","author":"Ba\u0161ov\u00e1","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102705_bib0042","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-3-031-62731-6_15","article-title":"MYB as a critical transcription factor and potential therapeutic target in AML","volume":"1459","author":"Clarke","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102705_bib0043","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s11684-022-0942-1","article-title":"ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt\/\u03b2-catenin signaling by palmitoylation modification","volume":"17","author":"Ye","year":"2023","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.tranon.2026.102705_bib0044","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1158\/1078-0432.CCR-19-2479","article-title":"EGFL7 Antagonizes NOTCH signaling and represents a novel therapeutic target in acute myeloid leukemia","volume":"26","author":"Bill","year":"2020","journal-title":"Clin. Can. Res. Offic. J. Am. Assoc. Can. Res."},{"key":"10.1016\/j.tranon.2026.102705_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2025.156883","article-title":"LINC-PINT suppresses the progression of acute myeloid leukemia via miR-767-5p\/SUZ12-mediated JAK\/STAT signaling pathway","volume":"188","author":"Xiang","year":"2025","journal-title":"Cytokine"},{"key":"10.1016\/j.tranon.2026.102705_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152064","article-title":"IRF2-driven upregulation of OAS3 promotes AML cell proliferation by modulating the JAK-STAT signaling pathway","volume":"772","author":"Zhang","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"16","key":"10.1016\/j.tranon.2026.102705_bib0047","doi-asserted-by":"crossref","first-page":"E962","DOI":"10.1073\/pnas.1121568109","article-title":"Repressor element-1 silencing transcription factor (REST)-dependent epigenetic remodeling is critical to ischemia-induced neuronal death","volume":"109","author":"Noh","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.tranon.2026.102705_bib0048","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/1878-0261.12903","article-title":"REST promotes ETS1-dependent vascular growth in medulloblastoma","volume":"15","author":"Shaik","year":"2021","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102705_bib0049","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajh.26496","article-title":"Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia","volume":"97","author":"Senapati","year":"2022","journal-title":"Am. J. Hematol."},{"issue":"21","key":"10.1016\/j.tranon.2026.102705_bib0050","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1056\/NEJMoa1605949","article-title":"TP53 and Decitabine in acute myeloid leukemia and myelodysplastic syndromes","volume":"375","author":"Welch","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.tranon.2026.102705_bib0051","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/1566523223666230724121515","article-title":"SFXN3 is associated with poor clinical outcomes and sensitivity to the hypomethylating therapy in non-M3 acute myeloid leukemia patients","volume":"23","author":"Dong","year":"2023","journal-title":"Curr. Gene. Ther."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:45:44Z","timestamp":1781527544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"alternative-id":["S1936523326000422"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102705","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"REST-driven upregulation of SFXN3 promotes AML progression via Wnt\/\u03b2-catenin activation and confers decitabine resistance","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102705"}}